1
|
Use of case-based reasoning to enhance intensive management of patients on insulin pump therapy.
|
J Diabetes Sci Technol
|
2008
|
1.26
|
2
|
Evaluating the automated blood glucose pattern detection and case-retrieval modules of the 4 Diabetes Support System.
|
J Diabetes Sci Technol
|
2010
|
1.05
|
3
|
Characterizing blood glucose variability using new metrics with continuous glucose monitoring data.
|
J Diabetes Sci Technol
|
2011
|
0.98
|
4
|
Type 2 diabetes mellitus: practical approaches for primary care physicians.
|
J Am Osteopath Assoc
|
2011
|
0.89
|
5
|
Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy.
|
J Diabetes Complications
|
2013
|
0.88
|
6
|
A consensus perceived glycemic variability metric.
|
J Diabetes Sci Technol
|
2013
|
0.86
|
7
|
Racial disparities in African Americans with diabetes: process and outcome mismatch.
|
Am J Manag Care
|
2012
|
0.83
|
8
|
Diabetes care in extended-care facilities: appropriate intensity of care?
|
Diabetes Care
|
2007
|
0.82
|
9
|
Analysis of use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in type 1 diabetes mellitus patients treated with multiple daily insulin injections.
|
J Diabetes Sci Technol
|
2012
|
0.80
|
10
|
Diabetes numeracy and blood glucose control: association with type of diabetes and source of care.
|
Clin Diabetes
|
2014
|
0.79
|
11
|
Treatment of specific macrovascular beds in patients with diabetes mellitus.
|
Osteopath Med Prim Care
|
2010
|
0.79
|
12
|
Evaluation of diabetes management in a rural community hospital.
|
Endocr Pract
|
2008
|
0.79
|
13
|
Evolution of "the guideline advantage": lessons learned from the front lines of outpatient performance measurement.
|
Circ Cardiovasc Qual Outcomes
|
2014
|
0.78
|
14
|
Use of and attitudes toward complementary and alternative medicine among osteopathic medical students.
|
J Am Osteopath Assoc
|
2012
|
0.78
|
15
|
How well are we managing diabetes in long-term care?
|
J Fam Pract
|
2012
|
0.78
|
16
|
Evolution of "the guideline advantage": lessons learned from the front lines of outpatient performance measurement.
|
Diabetes Care
|
2014
|
0.76
|
17
|
Glycated Hemoglobin Testing to Identify Undiagnosed Diabetes Mellitus in the Inpatient Setting.
|
J Am Osteopath Assoc
|
2016
|
0.75
|
18
|
Diabetes management within evolving health care delivery models: the osteopathic perspective.
|
J Am Osteopath Assoc
|
2015
|
0.75
|
19
|
Payer source influence on effectiveness of lifestyle medicine programs.
|
Am J Manag Care
|
2015
|
0.75
|
20
|
Vitamin D Deficiency, Its Role in Health and Disease, and Current Supplementation Recommendations.
|
J Am Osteopath Assoc
|
2017
|
0.75
|
21
|
Role of osteopathic structural diagnosis and osteopathic manipulative treatment for diabetes mellitus and its complications.
|
J Am Osteopath Assoc
|
2013
|
0.75
|
22
|
Effects of Osteopathic Manipulative Treatment on Diabetic Gastroparesis.
|
J Am Osteopath Assoc
|
2015
|
0.75
|
23
|
Effectiveness of the Complete Health Improvement Program in Reducing Risk Factors for Cardiovascular Disease in an Appalachian Population.
|
J Am Osteopath Assoc
|
2016
|
0.75
|
24
|
Cardiovascular Disease Risk Factors After an Employer-Based Risk Reduction Program: An Observational Cohort Study.
|
J Am Osteopath Assoc
|
2017
|
0.75
|
25
|
Be a "great physician" for your patients with type 2 diabetes mellitus.
|
J Am Osteopath Assoc
|
2012
|
0.75
|
26
|
Inpatient osteopathic structural examinations: is "red tape" getting in the way of personalized patient care?
|
J Am Osteopath Assoc
|
2008
|
0.75
|
27
|
Evolution of "The Guideline Advantage": Lessons learned from the front lines of outpatient performance measurement.
|
CA Cancer J Clin
|
2014
|
0.75
|
28
|
Employer-Funded Complete Health Improvement Program: Preliminary Results of Biomarker Changes.
|
J Am Osteopath Assoc
|
2017
|
0.75
|
29
|
Highlights From the American Diabetes Association's 2017 Standards of Medical Care in Diabetes for Osteopathic Physicians.
|
J Am Osteopath Assoc
|
2017
|
0.75
|
30
|
Leveraging the principles of osteopathic medicine to improve diabetes outcomes within a new era of health care reform.
|
J Am Osteopath Assoc
|
2015
|
0.75
|
31
|
GLP-1 agonists: improving the future of patients with type 2 diabetes.
|
J Am Osteopath Assoc
|
2011
|
0.75
|
32
|
Optimizing treatment for patients with diabetes mellitus: glycemic and nonglycemic effects.
|
J Am Osteopath Assoc
|
2011
|
0.75
|